SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001561743-16-000051
Filing Date
2016-03-04
Accepted
2016-03-04 12:52:31
Documents
73
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K kindredbio201510-k.htm 10-K 1695169
2 AUDITOR CONSENT exhibit231-201510k.htm EX-23.1 3449
3 EXHIBIT 31.1 exhibit311-201510k.htm EX-31.1 12987
4 EXHIBIT 32.1 exhibit321-201510k.htm EX-32.1 5760
11 image1a04.jpg GRAPHIC 96196
12 image2a05.jpg GRAPHIC 111748
  Complete submission text file 0001561743-16-000051.txt   7531686

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT kin-20151231.xml EX-101.INS 1489175
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kin-20151231.xsd EX-101.SCH 38225
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kin-20151231_cal.xml EX-101.CAL 67968
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kin-20151231_def.xml EX-101.DEF 247142
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kin-20151231_lab.xml EX-101.LAB 644304
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kin-20151231_pre.xml EX-101.PRE 395233
Mailing Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010
Business Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010 650-701-7901
Kindred Biosciences, Inc. (Filer) CIK: 0001561743 (see all company filings)

IRS No.: 461160142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36225 | Film No.: 161484405
SIC: 2834 Pharmaceutical Preparations